Prostate News Archive
29-Feb-2008
Blocking protein kills prostate cancer cells, inhibits tumor growth, Jefferson scientists find (PhysOrg)
Researchers at Jefferson`s Kimmel Cancer Center in Philadelphia have shown that they can effectively kill prostate cancer cells in both the laboratory and in experimental animal models by blocking a signaling protein that is key to the cancer`s growth. The work proves that the protein, Stat5, is both vital to prostate cancer cell maintenance and that it is a viable target for drug therapy. Web Tool Aids Men in Prostate Decisions (MedicineNet.com)
Title: Web Tool Aids Men in prostate Decisions Category: Health News Created: 2/27/2008 2:00:00 AM Last Editorial Review: 2/27/2008 New blood biomarker accurately predicts spread of prostate cancer to regional lymph nodes (News-Medical-Net)
Researchers report finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes. FDA Clears Cellsearch(TM) Circulating Tumor Cell Test For Monitoring Metastatic Prostate Cancer Patients (Medical News Today)
Veridex, LLC announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for the CellSearch(TM) System to be used as an aid in the monitoring of metastatic prostate cancer (MPC) patients. The CellSearch(TM) System currently is cleared for monitoring metastatic breast and metastatic colorectal cancer patients. New blood biomarker may help predict prostate cancer spread (New Kerala)
Washington, Feb 28 : Researchers at the University of Texas Southwestern Medical Center have reported finding a new blood biomarker that enables close to 98 percent accuracy in predicting the spread of prostate cancer to regional lymph nodes.
Back to Prostate News Archive
